Association between red blood cell transfusion and long-term mortality in patients with cancer of the esophagus after esophagectomy

2017 ◽  
Vol 31 (2) ◽  
Author(s):  
Joohyun Lee ◽  
Ji-Hyun Chin ◽  
Jong-Il Kim ◽  
Eun-Ho Lee ◽  
In-Cheol Choi
Keyword(s):  
Blood Cell ◽  
Red Blood Cell ◽  
Red Blood Cell Transfusion ◽  
Patients With Cancer ◽  
Cancer Of The Esophagus ◽  
Long Term Mortality

scholarly journals Limited effect of red blood cell transfusion on long-term mortality among anaemic cardiac surgery patients

2020 ◽  
Vol 31 (3) ◽  
pp. 375-382
Author(s):  
Long Tran ◽  
Guri Greiff ◽  
Alexander Wahba ◽  
Hilde Pleym ◽  
Vibeke Videm
Keyword(s):  
Risk Factors ◽  
Cardiac Surgery ◽  
Postoperative Complications ◽  
Blood Cell ◽  
Red Blood Cell ◽  
World Health ◽  
Red Blood Cell Transfusion ◽  
Rbc Transfusion ◽  
Long Term Mortality

Abstract OBJECTIVES Our goal was to investigate long-term mortality associated with red blood cell (RBC) transfusion among patients with anaemia undergoing cardiac surgery when adjusting for known risk factors. METHODS Adults with preoperative anaemia as defined by World Health Organization criteria undergoing open-heart surgery from 2000 through 2017 were included. Cox regression was performed for long-term mortality (30 days–5 years), comparing patients who received ≥1 unit of RBC with those who did not. Unadjusted and multivariable analyses adjusted for risk factors were performed. RESULTS The study included 1859 patients, 1525 (82%) of whom received RBC transfusion. A total of 370 (19.9%) deaths were registered between 30 days and 5 years; 88 patients (23.8%) died between 30 days and 1 year. The unadjusted hazard ratio (HR) associated with RBC transfusion was 2.09 (1.49–2.93, P < 0.001) from 30 days to 5 years postoperatively. The HR for RBC transfusion were 4.70 (1.72–12.81, P = 0.002) and 1.77 (1.23–2.55, P = 0.002) for 30 days–1 year and 1–5 years, respectively. Adjusting for perioperative risk factors, which included postoperative complications, the HR decreased to 1.16 (0.80–1.68, P = 0.43), 1.79 (0.63–5.12, P = 0.28) and 1.11 (0.75–1.65, P = 0.61) for observation time from 30 days to 5 years, 30 days to 1 year and 1 to 5 years, respectively. Results were similar when postoperative complications were excluded from the adjustment variables. CONCLUSIONS No statistically significant association between RBC transfusion and long-term mortality was found when we adjusted for known risk factors. This study suggests that the observed difference in mortality in this patient group is largely due to patient-related risk factors.

Effects of Red Blood Cell Transfusion on Long-Term Disability of Patients with Traumatic Brain Injury

2015 ◽  
Vol 24 (3) ◽  
pp. 371-380 ◽  
Author(s):  
Santiago R. Leal-Noval ◽  
Ángela Muñoz-Serrano ◽  
Victoria Arellano-Orden ◽  
Aurelio Cayuela ◽  
Manuel Muñoz-Gómez ◽  
...  
Keyword(s):  
Traumatic Brain Injury ◽  
Brain Injury ◽  
Blood Cell ◽  
Red Blood Cell ◽  
Red Blood Cell Transfusion

Red Blood Cell Transfusion And Long-Term Outcomes After Acute Lung Injury

2011 ◽  
Author(s):  
Elizabeth C. Parsons ◽  
Erin K. Kross ◽  
Ellen S. Caldwell ◽  
Timothy R. Watkins ◽  
Derek Angus ◽  
...  
Keyword(s):  
Acute Lung Injury ◽  
Lung Injury ◽  
Blood Cell ◽  
Red Blood Cell ◽  
Red Blood Cell Transfusion ◽  
Long Term Outcomes

Effects of Red Blood Cell Transfusion on Anemia-Related Symptoms in Patients with Cancer

2009 ◽  
Vol 12 (1) ◽  
pp. 60-63 ◽  
Author(s):  
Sebastiano Mercadante ◽  
Patrizia Ferrera ◽  
Patrizia Villari ◽  
Fabrizio David ◽  
Antonello Giarratano ◽  
...  
Keyword(s):  
Blood Cell ◽  
Red Blood Cell ◽  
Red Blood Cell Transfusion ◽  
Patients With Cancer
Sign in / Sign up

Export Citation Format

Share Document